Newbridge Financial Services Group’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-25
| Closed | -$241 | – | 1260 |
|
|
2023
Q3 | $241 | Hold |
25
| – | – | ﹤0.01% | 1235 |
|
|
2023
Q2 | $225 | Hold |
25
| – | – | ﹤0.01% | 1288 |
|
|
2023
Q1 | $197 | Hold |
25
| – | – | ﹤0.01% | 1350 |
|
|
2022
Q4 | $169 | Hold |
25
| – | – | ﹤0.01% | 1388 |
|
|
2022
Q3 | $0 | Hold |
25
| – | – | ﹤0.01% | 1429 |
|
|
2022
Q2 | $0 | Hold |
25
| – | – | ﹤0.01% | 1440 |
|
|
2022
Q1 | $0 | Hold |
25
| – | – | ﹤0.01% | 1500 |
|
|
2021
Q4 | $0 | Hold |
25
| – | – | ﹤0.01% | 1482 |
|
|
2021
Q3 | $1K | Hold |
25
| – | – | ﹤0.01% | 1273 |
|
|
2021
Q2 | $1K | Hold |
25
| – | – | ﹤0.01% | 1363 |
|
|
2021
Q1 | $1K | Buy |
+25
| New | +$1K | ﹤0.01% | 1283 |
|